BCR-ABL
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
SIGN UP FREE[{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1544108973/nlqiqhhrvecouzznlon1.svg#/keystone/api/icons/5c093bbc5c22a91200d6601b/bcr-abl.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5c093bbc5c22a91200d6601b/bcr-abl.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1544108973/kezamuzuvnzowof7x9k1.svg#/keystone/api/icons/5c093bbc5c22a91200d6601a/bcr-abl.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5c093bbc5c22a91200d6601a/bcr-abl.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1544108973/stnjcpaxdlwg4uaqcrvt.svg#/keystone/api/icons/5c093bbc5c22a91200d66019/bcr-abl.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5c093bbc5c22a91200d66019/bcr-abl.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1544108973/qo3unxwzwnfwkxpeynfs.svg#/keystone/api/icons/5c093bbc5c22a91200d66018/bcr-abl.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5c093bbc5c22a91200d66018/bcr-abl.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1544108973/nz7qmexu9ix8uc9zyqqc.svg#/keystone/api/icons/5c093bbc5c22a91200d66017/bcr-abl.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5c093bbc5c22a91200d66017/bcr-abl.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1544108973/w4d83ikjd5xz5qlsem11.svg#/keystone/api/icons/5c093bbc5c22a91200d66016/bcr-abl.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5c093bbc5c22a91200d66016/bcr-abl.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1544108973/mz9p21c6wiizokx97i1n.svg#/keystone/api/icons/5c093bbc5c22a91200d66015/bcr-abl.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5c093bbc5c22a91200d66015/bcr-abl.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1544108973/b1ktr3tohhurj0doqrg9.svg#/keystone/api/icons/5c093bbc5c22a91200d66014/bcr-abl.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5c093bbc5c22a91200d66014/bcr-abl.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1544108973/ed4mpjewcodkx9gickse.svg#/keystone/api/icons/5c093bbc5c22a91200d66013/bcr-abl.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5c093bbc5c22a91200d66013/bcr-abl.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1544108973/ckrqerxqiiw5aakubvqd.svg#/keystone/api/icons/5c093bbc5c22a91200d66012/bcr-abl.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5c093bbc5c22a91200d66012/bcr-abl.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1544108973/gbbqgysp5gfjkqytrdqi.svg#/keystone/api/icons/5c093bbc5c22a91200d66011/bcr-abl.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5c093bbc5c22a91200d66011/bcr-abl.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1544108973/ixvmm5gsqsxinykraaoi.svg#/keystone/api/icons/5c093bbc5c22a91200d66010/bcr-abl.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5c093bbc5c22a91200d66010/bcr-abl.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1544108973/pvm5iqfb2l8yvegysjaq.svg#/keystone/api/icons/5c093bbc5c22a91200d6600f/bcr-abl.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5c093bbc5c22a91200d6600f/bcr-abl.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1544108973/cyrsnuwqpkvcbugi8gk5.svg#/keystone/api/icons/5c093bbc5c22a91200d6600e/bcr-abl.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5c093bbc5c22a91200d6600e/bcr-abl.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1544108973/ml8yatu9wwmuucimljf0.svg#/keystone/api/icons/5c093bbc5c22a91200d6600d/bcr-abl.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5c093bbc5c22a91200d6600d/bcr-abl.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1544108973/artgzcmid7infa4jchsh.svg#/keystone/api/icons/5c093bbc5c22a91200d6600c/bcr-abl.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5c093bbc5c22a91200d6600c/bcr-abl.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1544108973/svtw95l3suynrfkyvggv.svg#/keystone/api/icons/5c093bbc5c22a91200d6600b/bcr-abl.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5c093bbc5c22a91200d6600b/bcr-abl.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1544108973/ilitrc4w1ylyh6ovenam.svg#/keystone/api/icons/5c093bbc5c22a91200d6600a/bcr-abl.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5c093bbc5c22a91200d6600a/bcr-abl.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1544108973/dmbjxt84qksnojolwcxe.svg#/keystone/api/icons/5c093bbc5c22a91200d66009/bcr-abl.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5c093bbc5c22a91200d66009/bcr-abl.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1544108973/wywl4jvrdosaga2laaqy.svg#/keystone/api/icons/5c093bbc5c22a91200d66008/bcr-abl.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5c093bbc5c22a91200d66008/bcr-abl.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1544108973/ponotpe35tu156tsnv0r.svg#/keystone/api/icons/5c093bbc5c22a91200d66007/bcr-abl.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5c093bbc5c22a91200d66007/bcr-abl.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1544108973/qgtvsunywgqkqnbeen6l.svg#/keystone/api/icons/5c093bbc5c22a91200d66006/bcr-abl.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5c093bbc5c22a91200d66006/bcr-abl.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1544108973/hu9ikf3w4rgrgubrvowj.svg#/keystone/api/icons/5c093bbc5c22a91200d66005/bcr-abl.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5c093bbc5c22a91200d66005/bcr-abl.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1544108973/ishynbeg6rq9pkbhgwgx.svg#/keystone/api/icons/5c093bbc5c22a91200d66004/bcr-abl.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5c093bbc5c22a91200d66004/bcr-abl.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1544108973/d4tephgybnuzdpfntrz2.svg#/keystone/api/icons/5c093bbc5c22a91200d66003/bcr-abl.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/5c093bbc5c22a91200d66003/bcr-abl.png"}]
Keywords
tyrosine kinase inhibitor,TKI,CML,chronic myelogenous leukemia,oncogene,Bcr-Abl,philadelphia chromosome,philadelphia translocation,Ph,abl gene